Study of autoantibodies to DNA in schizophrenia and other neuropsychiatric disorders
Ismailov, T.I.
Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 72(8): 1188-1191
1972
ISSN/ISBN: 0044-4588 PMID: 5078322 Document Number: 49188
Document emailed within 1 workday
Related Documents
Singh, V.K.; Fudenberg, H.H. 1986: Can blood immunocytes be used to study neuropsychiatric disorders? Journal of Clinical Psychiatry 47(12): 592-595Bowie, C.R.; Harvey, P.D. 2006: Schizophrenia from a neuropsychiatric perspective Mount Sinai Journal of Medicine new York 73(7): 993-998
Kile, S.J. 2007: Neuropsychiatric update: neuroimaging schizophrenia Psychopharmacology Bulletin 40(4): 156-167
Hirohata, S.; Sakuma, Y.; Matsueda, Y.; Arinuma, Y.; Yanagida, T. 2018: Role of serum autoantibodies in blood brain barrier damages in neuropsychiatric systemic lupus erythematosus Clinical and Experimental Rheumatology 36(6): 1003-1007
Astakhova, L.N.; Asanova, N.K. 1985: Borderline neuropsychiatric disorders in purine metabolism disorders in children Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 85(3): 421-426
Zaytseva, Y.; Burova, V.; Garakh, Z.; Gurovich, I.Y. 2013: Attributional style in fist episode of schizophrenia and schizophrenia spectrum disorders with and without paranoid ideation Psychiatria Danubina 25(Suppl 2): S329-S331
Olsen, D.B.; Abraham, J.H. 1999: Neuropsychiatric disorders in insulinoma Ugeskrift for Laeger 161(10): 1420-1421
Schooler, N.R.; Keith, S.J.; Severe, J.B.; Matthews, S. 1989: Acute treatment response and short term outcome in schizophrenia: first results of the NIMH treatment strategies in schizophrenia study. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 331-335
Nnadi, C.U.; Mimiko, O.A.; McCurtis, H.L.; Cadet, J.L. 2005: Neuropsychiatric effects of cocaine use disorders Journal of the National Medical Association 97(11): 1504-1515
Wilson, P. 2007: Recognising childhood neuropsychiatric disorders Practitioner 251(1697): 26-27; 29-30
Yamazaki, K. 1970: Neuroendocrinological investigations in mental disorders, particularly in terms of pyrogen test. II. a study in schizophrenia and manic psychosis Seishin Shinkeigaku Zasshi 72(5): 467-483
Perello, D.J. 1971: Voice disorders of neurological or neuropsychiatric origin Journal Francais d'Oto-Rhino-Laryngologie Audio-Phonologie et Chirurgie Maxillo-Faciale 20(3): 499-502
Todder, D.; Grisaru, N.; Kaplan, Z. 2016: Noninvasive Brain Stimulation in Neuropsychiatric Disorders Harefuah 155(12): 753-756
Rehavi, M.; Weizman, R.; Weizman, A. 1988: Platelets as neuronal models in neuropsychiatric disorders Progress in Clinical and Biological Research 283: 569-583
Kolupaev, G.P.; Lukomskiĭ, M.I. 1974: Neuropsychiatric disorders in myocardial infarct patients Voenno-Meditsinskii Zhurnal 7: 35-36
Shcherbakova, I.V.; Efanova, N.N.; Orlova, V.A.; Kliushnik, T.P.; Voskresenskaia, N.I.; Gubskiĭ, A.V.; Kupriianov, D.A.; Ganisheva, T.K.; Anisimov, N.V. 2009: MRI-parameters of frontal lobes in schizophrenia: correlations with the level of autoantibodies to nerve growth factor in the blood serum Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 109(3): 44-46
Nunomura, A.; Tamaoki, T.; Motohashi, N. 2014: Role of oxidative stress in the pathophysiology of neuropsychiatric disorders Seishin Shinkeigaku Zasshi 116(10): 842-858
Buretić-Tomljanović, A.; Tomljanović, D. 2009: Human genome variation in health and in neuropsychiatric disorders Psychiatria Danubina 21(4): 562-569
Williams, D.T.; Ford, B.; Fahn, S. 2005: Treatment issues in psychogenic-neuropsychiatric movement disorders Advances in Neurology 96: 350-363
Hoyer, D. 2007: RNA interference for studying the molecular basis of neuropsychiatric disorders Current Opinion in Drug Discovery and Development 10(2): 122-129